Since high plasma NfL concentrations are also found in other NDDs [28], further evidence is needed to demonstrate whether plasma NfL concentrations increase already in preclinical and prodromal stages of AD and whether such alterations may be indicative of early neural changes specific for AD. The gene discussed is NEFL; the disease is Alzheimer disease.